Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.

Abboud N, Ghazouani L, Saidi S, Ben-Hadj-Khalifa S, Addad F, Almawi WY, Mahjoub T.

Genet Test Mol Biomarkers. 2010 Feb;14(1):23-7. doi: 10.1089/gtmb.2009.0039.

PMID:
19929406
2.

Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.

Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY.

J Stroke Cerebrovasc Dis. 2007 Jul-Aug;16(4):153-9.

PMID:
17689411
3.

Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.

Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY.

Diabetes Metab. 2009 Jun;35(3):214-9. doi: 10.1016/j.diabet.2008.12.002.

4.

Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.

Magdoud K, Herbepin VG, Touraine R, Almawi WY, Mahjoub T.

Am J Reprod Immunol. 2013 Sep;70(3):246-52. doi: 10.1111/aji.12116.

PMID:
23521508
5.

Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.

Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.

Chin Med J (Engl). 2001 Mar;114(3):266-9.

PMID:
11780311
6.

Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.

Ding J, Nicklas BJ, Fallin MD, de Rekeneire N, Kritchevsky SB, Pahor M, Rodondi N, Li R, Zmuda JM, Harris TB.

Am Heart J. 2006 Dec;152(6):1109-15.

PMID:
17161063
7.

Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction.

Rallidis LS, Gialeraki A, Merkouri E, Liakos G, Dagres N, Sionis D, Travlou A, Lekakis J, Kremastinos DT.

J Thromb Thrombolysis. 2010 May;29(4):497-502. doi: 10.1007/s11239-009-0398-z.

PMID:
19844663
8.
9.

The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.

Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR.

Thromb Haemost. 1999 Jul;82(1):115-20.

PMID:
10456464
10.

Allele-specific transcription of the PAI-1 gene in human astrocytes.

Hultman K, Tjarnlund-Wolf A, Odeberg J, Eriksson P, Jern C.

Thromb Haemost. 2010 Nov;104(5):998-1008. doi: 10.1160/TH10-04-0243.

PMID:
20806116
11.

The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.

Iwai N, Shimoike H, Nakamura Y, Tamaki S, Kinoshita M.

Atherosclerosis. 1998 Jan;136(1):109-14.

PMID:
9544737
12.
13.

Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.

Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.

J Clin Periodontol. 2007 Apr;34(4):278-84.

PMID:
17257155
14.

Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH.

Thromb Res. 2012 Sep;130(3):e43-51. doi: 10.1016/j.thromres.2012.06.015.

PMID:
22771216
15.

Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.

Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.

J Periodontol. 2007 Jul;78(7):1256-63.

PMID:
17608581
17.

Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.

Espino A, Villagrán A, Vollrath V, Hanckes P, Salas R, Farah A, Solís N, Pizarro M, Escalona A, Boza C, Pérez G, Carrasco G, Padilla O, Miquel JF, Nervi F, Chavez-Tapia NC, Arab JP, Alvarez-Lobos M, Arrese M, Riquelme A.

Ann Hepatol. 2011 Oct-Dec;10(4):493-501.

18.

Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study.

Morange PE, Saut N, Alessi MC, Yudkin JS, Margaglione M, Di Minno G, Hamsten A, Humphries SE, Tregouet DA, Juhan-Vague I.

Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2250-7.

19.

Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population.

Sugano T, Tsuji H, Masuda H, Nakagawa K, Nishimura H, Kasahara T, Yoshizumi M, Nakahara Y, Kitamura H, Yamada K, Yoneda M, Maki K, Tatsumi T, Azuma A, Nakagawa M.

Blood Coagul Fibrinolysis. 1998 Mar;9(2):201-4.

PMID:
9622220
20.

The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.

Juhan-Vague I, Morange PE, Frere C, Aillaud MF, Alessi MC, Hawe E, Boquist S, Tornvall P, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Humphries SE; HIFMECH Study Group..

J Thromb Haemost. 2003 Nov;1(11):2322-9.

Supplemental Content

Support Center